Date | Net Cash Used Provided By Financing Activities | Dividends Paid | Capital Expenditure | Effect Of Forex Changes On Cash |
---|
CEO | Mr. Michael C. Kavanagh BSc, M.B.A. |
IPO Date | May 17, 2007 |
Location | Australia |
Headquarters | Building A |
Employees | 466 |
Sector | Health Care |
Industries |
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Past 5 years
USD 9.31
USD 157.25
USD 73.92
USD 1.59
StockViz Staff
January 15, 2025
Any question? Send us an email